Management strategies in hypertrophic cardiomyopathy: Influence of age and morphology

European Heart Journal, Supplement

Volumn 3, Issue L, 2001, Pages

  McKenna, William J ^a   Sharma, S ^a   Elliott, P M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Children; Hyper trophy; Hypertrophic cardiomyopathy; Infants; Sudden death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE;

ADOLESCENT; ADULT; ARTICLE; CARDIOVERSION; CHILD; DEFIBRILLATOR; FAMILY HISTORY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH; SYNCOPE; URINE RETENTION;

EID: 0035152612     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(01)90058-6     Document Type: Article

References (28)

1. Cardiomyopathies
2. Management of hypertrophic cardiomyopathy
3. Genetic basis of inherited cardiomyopathies
4. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy
5. Mutations in the cardiac myosin binding protein-C gene on chromosome II cause familial hypertrophic cardiomyopathy
6. A splice acceptor site mutation in the cardiac myosin binding protein C gene is associated with familial hypertrophic cardiomyopathy
7. Prevalence of hypertrophic cardiomyopathy in a population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults
8. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy
9. Muscular subaortic stenosis: Hemodynamic and clinical improvement after disopyramide
10. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
11. Therapeutic approaches to the management of obstruction in hypertrophic cardiomyopathy
12. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: Long term follow up of the first series of 25 patients
13. 'Sawfish' systolic narrowing of the left anterior descending coronary artery: An angiographic sign of hypertrophic cardiomyopathy
14. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: Association with left ventricular apical aneurysm
15. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration
16. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3
17. Hypertrophic cardiomyopathy without hypertrophy: Two families with myocardial disarray in the absence of increased myocardial mass
18. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
19. Relation between the severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
20. The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy
21. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia
22. Cireadian variations in the incidence and characteristics of non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
23. Hypertrophic cardiomyopathy: An important cause of sudden death
24. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy
25. Prospective assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy
26. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia
27. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population
28. Efficacy of the implantable cardioverter-defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy